Back to results
US 8,946,278 B2Granted
Inhibitors of AkT activity
AssigneeGlaxoSmithKline LLC
InventorsMark A. Seefeld, Meagan B. Rouse, Dirk A. Heerding, Dennis S. Yamashita, Kenneth C. McNulty
Life of this patent
Estimating the term…
Abstract
Invented are novel heterocyclic carboxamide compounds, the use of such compounds as inhibitors of protein kinase B activity and in the treatment of cancer and arthritis.
Claims15
A compound of Formula (I),
- wherein:
- R41 is selected from:
- chlorine, ethyl, methyl and methoxy;
- R42 is
- where Q is nitrogen, Y is —CH— and Z is —C(R48)—, and
- R30 is selected from methyl and ethyl,
- where R48 is selected from:
- hydrogen, methyl, chlorine and bromine;
- R43 is hydrogen;
- R44 is —CH2-phenyl wherein the phenyl is substituted by one or two substituents selected from fluorine and trifluoromethyl;
- R45 is hydrogen;
- R20 is hydrogen;
- X is selected from O and S;
- and
- n is 1;
- or a pharmaceutically acceptable salt thereof.
13 more elements
Dependencies are inferred from the claim text.